Table 2.

Treg proportion in peripheral blood from pancreatic cancer patients and healthy control

Group	N	CD25+/CD4+	FoxP3/CD4+	CD25+FoxP3/CD4+
Healthy control	20	2.69±0.26	1.20±0.14	0.47±0.04
Early stage	5	3.11±0.45*,##	1.22±0.21##	0.56±0.07**,##
Progression stage	15	4.20±0.40**	1.76±0.28**	0.95±0.18**
Advanced stage	20	4.32±0.58**	1.87±0.29**	1.01±0.17**

^* P<0.05 compared with healthy control;

^** P<0.01 compared with healthy control;

^## P<0.01 compared with progression stage group.